| Application no. and date | 15772163.0 (espacenet) (Federated) (European Patent Register), 20150918 | | Patent/reg. no. and date | DK/EP 3193830, 20231101 | | Publication date | 20170726 | | Priority no. and date | US 201462052948 P, 20140919 | | EP pub. no. and date |
EP 3193830 20170726 | | Effective date | | | Applicant/owner | Heron Therapeutics, Inc., 4242 Campus Point Court Suite 200
San Diego CA 92121, US | | Applicant ref. no. | | | Inventor | OTTOBONI, Thomas, B., 1211 North Road
Belmont, CA 94002, US,
HAN, Han, 2209 Hastings Drive Apt. 60
Belmont, CA 94002, US | | Representative | | | Opponent | | | IPC Class | A61K 31/53 (2006.01) , A61K 47/10 (2017.01) , A61K 47/12 (2006.01) , A61K 47/24 (2006.01) , A61K 47/26 (2006.01) , A61K 47/44 (2017.01) , A61K 9/00 (2006.01) , A61P 1/08 (2006.01) , A61P 43/00 (2006.01) | | Title | EMULSON FORMULATIONS OF APREPITANT | | Int. application no. | US2015051050 | | Int. publication no. | WO2016044784 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
